Xencor Inc(XNCR)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

XNCR Xencor Inc

休市中 10-23 16:00:00 EDT

25.18

-0.66

-2.55%

盘后25.55

+0.37+1.47%

19:30 EDT

最高25.81	最低24.42	成交量145.81万
今开25.52	昨收25.84	日振幅5.38%
总市值18.67亿	流通市值13.66亿	总股本7,413万
成交额3,652万	换手率2.69%	流通股本5,425万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"XNCR","market":"US","secType":"STK","nameCN":"Xencor Inc","latestPrice":25.18,"timestamp":1792785600000,"preClose":25.84,"halted":0,"volume":1458064,"hourTrading":{"tag":"盘后","latestPrice":25.55,"preClose":25.18,"latestTime":"19:30 EDT","volume":8933,"amount":226479.38,"timestamp":1792798204100,"change":0.37,"changeRate":0.014694,"amplitude":0.015091},"delay":0,"changeRate":-0.025541795665634682,"floatShares":54251400,"shares":74127400,"eps":-2.176824,"marketStatus":"休市中","change":-0.66,"latestTime":"10-23 16:00:00 EDT","open":25.52,"high":25.81,"low":24.42,"amount":36520296.68536,"amplitude":0.053793,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.176824,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1793001600000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1386046800000,"exchange":"NASDAQ","adjPreClose":25.84,"preHourTrading":{"tag":"盘前","latestPrice":26.1687,"preClose":25.84,"latestTime":"09:14 EDT","volume":40,"amount":1060.46072,"timestamp":1792761291847,"change":0.3287,"changeRate":0.012721,"amplitude":0.094427},"postHourTrading":{"tag":"盘后","latestPrice":25.55,"preClose":25.18,"latestTime":"19:30 EDT","volume":8933,"amount":226479.38,"timestamp":1792798204100,"change":0.37,"changeRate":0.014694,"amplitude":0.015091},"volumeRatio":1.1273430388243986,"impliedVol":2.2515,"impliedVolPercentile":0.9801},"requestUrl":"/m/hq/s/XNCR","defaultTab":"news","newsList":[{"id":"1170785579","title":"Xencor宣布将在2026年ESMO大会进行Xmab819治疗晚期透明细胞肾细胞癌一期临床研究的优选论文口头报告","url":"https://stock-news.laohu8.com/highlight/detail?id=1170785579","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1170785579?lang=zh_cn&edition=full","pubTime":"2026-07-17 21:12","pubTimestamp":1784293930,"startTime":"0","endTime":"0","summary":"Xencor公司宣布，其针对Xmab819在晚期透明细胞肾细胞癌患者中开展的一期临床研究，已被选为2026年欧洲肿瘤内科学会大会的优选论文，并将进行口头报告。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XNCR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517430772","title":"Xencor, Inc.2024财年实现净利润-2.33亿美元，同比减少75.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517430772","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517430772?lang=zh_cn&edition=full","pubTime":"2025-03-08 00:00","pubTimestamp":1741363251,"startTime":"0","endTime":"0","summary":"3月8日，Xencor, Inc.公布财报，公告显示公司2024财年净利润为-2.33亿美元，同比减少75.19%；其中营业收入为1.10亿美元，同比减少37.14%，每股基本收益为-3.58美元。从资产负债表来看，Xencor, Inc.总负债2.78亿美元，其中短期债务51.46百万美元，资产负债比为3.43，流动比率为0.07。机构评级：截至2025年3月8日，当前有10家机构对Xencor, Inc.目标价做出预测，其中目标均价为30.30美元，其中最低目标价为22.00美元，最高目标价为40.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250308000218a2647f5f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250308000218a2647f5f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XNCR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516634986","title":"Xencor, Inc.盘中异动 下午盘快速跳水5.05%报14.59美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516634986","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516634986?lang=zh_cn&edition=full","pubTime":"2025-03-04 04:29","pubTimestamp":1741033747,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日04时29分，Xencor, Inc.股票出现波动，股价急速下挫5.05%。截至发稿，该股报14.59美元/股，成交量37.7305万股，换手率0.54%，振幅5.63%。Xencor, Inc.股票所在的生物技术行业中，整体跌幅为0.11%。其相关个股中，Bioxcel Therapeutics, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 、Entero Therapeutics Inc.涨幅较大，Bioxcel Therapeutics, Inc.、Allarity Therapeutics, Inc.、Entero Therapeutics Inc.较为活跃，换手率分别为4611.46%、215.05%、186.61%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Radiopharm Theranostics Limited、Entero Therapeutics Inc.，振幅分别为206.20%、119.50%、70.53%。Xencor, Inc.公司简介：Xencor Inc 是一家位于美国的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503040429079637fc0b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503040429079637fc0b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XNCR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516377311","title":"富国银行：维持Xencor(XNCR.US)评级，由增持调整至增持评级, 目标价由37.00美元调整至33.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2516377311","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516377311?lang=zh_cn&edition=full","pubTime":"2025-03-01 01:31","pubTimestamp":1740763885,"startTime":"0","endTime":"0","summary":"富国银行：维持Xencor(XNCR.US)评级，由增持调整至增持评级, 目标价由37.00美元调整至33.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/01013148469988.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["XNCR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514385233","title":"Xencor, Inc.盘中异动 快速拉升5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514385233","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514385233?lang=zh_cn&edition=full","pubTime":"2025-02-27 22:34","pubTimestamp":1740666888,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日22时34分，Xencor, Inc.股票出现波动，股价大幅拉升5.01%。Xencor, Inc.股票所在的生物技术行业中，整体涨幅为0.42%。其相关个股中，Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Pasithea Therapeutics Corp C/Wts 12/08/2026 、Alector, Inc.涨幅较大，Quoin Pharmaceuticals Ltd、Moleculin Biotech, Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为429.63%、92.78%、66.03%，振幅较大的相关个股有Channel Therapeutics Corporation、Quoin Pharmaceuticals Ltd、Neurosense Therapeutics Ltd C/Wts 10/11/2026 ，振幅分别为16.14%、15.14%、14.83%。Xencor, Inc.公司简介：Xencor Inc 是一家位于美国的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227223449989510a0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227223449989510a0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XNCR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168323239","title":"Xencor第四季度每股亏损$(0.62)好于预期$(0.78)，销售额$52.79M超预期$19.48M","url":"https://stock-news.laohu8.com/highlight/detail?id=1168323239","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1168323239?lang=zh_cn&edition=full","pubTime":"2025-02-27 21:25","pubTimestamp":1740662707,"startTime":"0","endTime":"0","summary":"Xencor 报告的季度每股亏损为$，好于分析师预期的$，超出20.51%。相比去年同期销售额$50.97M，本季度销售额增长了3.59%。以上内容来自Benzinga Earnings专栏，原文如下：Xencor  reported quarterly losses of $ per share which beat the analyst consensus estimate of $ by 20.51 percent. This is a 44.19 percent decrease over losses of $ per share from the same period last year. The company reported quarterly sales of $52.79 million which beat the analyst consensus estimate of $19.48 million by 171.05 percent. This is a 3.59 percent increase over sales of $50.97 millio","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Xencor第四季度每股亏损$(0.62)好于预期$(0.78)，销售额$52.79M超预期$19.48M","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XNCR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2506894173","title":"Xencor, Inc.盘中异动 股价大跌5.08%报19.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2506894173","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2506894173?lang=zh_cn&edition=full","pubTime":"2025-01-25 03:09","pubTimestamp":1737745755,"startTime":"0","endTime":"0","summary":"北京时间2025年01月25日03时09分，Xencor, Inc.股票出现异动，股价急速下挫5.08%。截至发稿，该股报19.42美元/股，成交量14.6523万股，换手率0.21%，振幅5.13%。Xencor, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Neuphoria Therapeutics Inc.、Evaxion Biotech As、Pmgc Holdings Inc.涨幅较大，Evaxion Biotech As、Pmgc Holdings Inc.、Transcode Therapeutics, Inc.较为活跃，换手率分别为4300.35%、2362.24%、1715.58%，振幅较大的相关个股有Neuphoria Therapeutics Inc.、Celularity Inc C/Wts 16/07/2026 、Evaxion Biotech As，振幅分别为261.67%、220.61%、137.09%。Xencor, Inc.公司简介：Xencor Inc 是一家位于美国的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250125030916abb78b57&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250125030916abb78b57&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XNCR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505789468","title":"Xencor, Inc.盘中异动 快速拉升5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505789468","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2505789468?lang=zh_cn&edition=full","pubTime":"2025-01-22 04:10","pubTimestamp":1737490210,"startTime":"0","endTime":"0","summary":"北京时间2025年01月22日04时10分，Xencor, Inc.股票出现异动，股价快速上涨5.15%。截至发稿，该股报20.23美元/股，成交量26.2472万股，换手率0.38%，振幅5.07%。Xencor, Inc.股票所在的生物技术行业中，整体涨幅为1.87%。其相关个股中，Dogwood Therapeutics, Inc.、Camp4 Therapeutics Corporation、Channel Therapeutics Corporation涨幅较大，Dogwood Therapeutics, Inc.、Channel Therapeutics Corporation、Dermata Therapeutics, Inc.较为活跃，换手率分别为1052.00%、526.21%、190.70%，振幅较大的相关个股有Channel Therapeutics Corporation、Dogwood Therapeutics, Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026，振幅分别为96.32%、69.49%、50.37%。Xencor, Inc.公司简介：Xencor Inc 是一家位于美国的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122041010abb38e37&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122041010abb38e37&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XNCR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503251886","title":"Xencor, Inc.盘中异动 早盘股价大涨5.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503251886","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503251886?lang=zh_cn&edition=full","pubTime":"2025-01-15 23:23","pubTimestamp":1736954594,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日23时23分，Xencor, Inc.股票出现波动，股价急速上涨5.39%。Xencor, Inc.股票所在的生物技术行业中，整体涨幅为1.39%。其相关个股中，Klotho Neurosciences Inc C/Wts 21/06/2029 、Lexaria Bioscience Corp C/Wts 14/01/2026 、Neurosense Therapeutics Ltd C/Wts 10/11/2026 涨幅较大，Windtree Therapeutics, Inc.、Phio Pharmaceuticals Corp.、Os Therapies Incorporated较为活跃，换手率分别为205.05%、141.51%、78.00%，振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Os Therapies Incorporated、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 ，振幅分别为68.03%、61.30%、54.40%。Xencor, Inc.公司简介：Xencor Inc 是一家位于美国的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115232314a2230ba2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115232314a2230ba2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XNCR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503635701","title":"Xencor, Inc.盘中异动 下午盘快速下跌5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503635701","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503635701?lang=zh_cn&edition=full","pubTime":"2025-01-15 04:05","pubTimestamp":1736885109,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日04时05分，Xencor, Inc.股票出现波动，股价大幅下挫5.13%。截至发稿，该股报19.22美元/股，成交量31.5518万股，换手率0.45%，振幅6.12%。Xencor, Inc.股票所在的生物技术行业中，整体跌幅为1.27%。Xencor, Inc.公司简介：Xencor Inc 是一家位于美国的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115040509a221fdb6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115040509a221fdb6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XNCR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2502062895","title":"Xencor, Inc.盘中异动 急速跳水5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2502062895","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2502062895?lang=zh_cn&edition=full","pubTime":"2025-01-10 23:03","pubTimestamp":1736521434,"startTime":"0","endTime":"0","summary":"北京时间2025年01月10日23时03分，Xencor, Inc.股票出现波动，股价急速下跌5.04%。截至发稿，该股报22.25美元/股，成交量7.3492万股，换手率0.11%，振幅2.07%。Xencor, Inc.股票所在的生物技术行业中，整体跌幅为1.06%。其相关个股中，Conduit Pharmaceuticals Inc.、Precision Biosciences, Inc.、Jasper Therapeutics Inc C/Wts 24/09/2026 涨幅较大，Zyversa Therapeutics, Inc.、Conduit Pharmaceuticals Inc.、Precision Biosciences, Inc.较为活跃，换手率分别为1089.24%、314.58%、193.47%，振幅较大的相关个股有Conduit Pharmaceuticals Inc.、Precision Biosciences, Inc.、Zyversa Therapeutics, Inc.，振幅分别为72.56%、41.78%、37.29%。Xencor, Inc.公司简介：Xencor Inc 是一家位于美国的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011023035595ff758c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011023035595ff758c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XNCR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2492929156","title":"Xencor, Inc.盘中异动 急速下跌5.09%报23.77美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492929156","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2492929156?lang=zh_cn&edition=full","pubTime":"2024-12-19 04:31","pubTimestamp":1734553890,"startTime":"0","endTime":"0","summary":"北京时间2024年12月19日04时31分，Xencor, Inc.股票出现波动，股价大幅下跌5.09%。截至发稿，该股报23.77美元/股，成交量45.3138万股，换手率0.65%，振幅6.87%。Xencor, Inc.股票所在的生物技术行业中，整体跌幅为2.41%。Xencor, Inc.公司简介：Xencor Inc 是一家位于美国的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219043131ab829c6e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219043131ab829c6e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XNCR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2492461672","title":"Xencor, Inc.盘中异动 早盘股价大涨5.08%报25.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492461672","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2492461672?lang=zh_cn&edition=full","pubTime":"2024-12-16 23:55","pubTimestamp":1734364545,"startTime":"0","endTime":"0","summary":"北京时间2024年12月16日23时55分，Xencor, Inc.股票出现波动，股价急速上涨5.08%。截至发稿，该股报25.25美元/股，成交量7.9489万股，换手率0.11%，振幅6.03%。Xencor, Inc.股票所在的生物技术行业中，整体涨幅为0.69%。Xencor, Inc.公司简介：Xencor Inc 是一家位于美国的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216235546984c730d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216235546984c730d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XNCR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2491334830","title":"Xencor, Inc.盘中异动 急速拉升5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2491334830","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2491334830?lang=zh_cn&edition=full","pubTime":"2024-12-13 01:02","pubTimestamp":1734022956,"startTime":"0","endTime":"0","summary":"北京时间2024年12月13日01时02分，Xencor, Inc.股票出现异动，股价大幅拉升5.11%。Xencor, Inc.股票所在的生物技术行业中，整体跌幅为1.03%。其相关个股中，Palisade Bio, Inc.、Tc Biopharm  Plc C/Wts 10/02/2028 、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 涨幅较大，Palisade Bio, Inc.、Aptevo Therapeutics Inc.、Conduit Pharmaceuticals Inc.较为活跃，换手率分别为3575.32%、911.28%、83.00%，振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com，振幅分别为129.16%、86.92%、80.04%。Xencor, Inc.公司简介：Xencor Inc 是一家位于美国的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213010236a1e99541&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213010236a1e99541&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XNCR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2488267759","title":"Xencor, Inc.盘中异动 急速拉升5.06%报26.90美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2488267759","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2488267759?lang=zh_cn&edition=full","pubTime":"2024-12-02 22:39","pubTimestamp":1733150365,"startTime":"0","endTime":"0","summary":"北京时间2024年12月02日22时39分，Xencor, Inc.股票出现波动，股价大幅上涨5.06%。截至发稿，该股报26.90美元/股，成交量2.6113万股，换手率0.04%，振幅1.62%。Xencor, Inc.股票所在的生物技术行业中，整体跌幅为0.05%。Xencor, Inc.公司简介：Xencor Inc 是一家位于美国的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202223926971b2e71&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202223926971b2e71&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XNCR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2486036870","title":"Xencor, Inc.盘中异动 早盘股价大涨5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486036870","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2486036870?lang=zh_cn&edition=full","pubTime":"2024-11-25 23:21","pubTimestamp":1732548061,"startTime":"0","endTime":"0","summary":"北京时间2024年11月25日23时21分，Xencor, Inc.股票出现异动，股价大幅上涨5.08%。截至发稿，该股报26.28美元/股，成交量5.9334万股，换手率0.08%，振幅2.98%。Xencor, Inc.股票所在的生物技术行业中，整体涨幅为1.93%。Xencor, Inc.公司简介：Xencor Inc 是一家位于美国的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125232101971a867c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125232101971a867c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XNCR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.xencor.com","stockEarnings":[{"period":"1week","weight":0.102},{"period":"1month","weight":0.0379},{"period":"3month","weight":0.2953},{"period":"6month","weight":0.9399},{"period":"1year","weight":1.0405},{"period":"ytd","weight":0.6447}],"compareEarnings":[{"period":"1week","weight":-0.0043},{"period":"1month","weight":-0.0102},{"period":"3month","weight":0.0285},{"period":"6month","weight":0.0645},{"period":"1year","weight":0.1313},{"period":"ytd","weight":0.1145}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Xencor, Inc.在加利福尼亚州成立于1997年8月，2004年9月在特拉华州重组。该公司是一家临床阶段的生物制药公司，专注于发现和开发工程化的单克隆抗体和细胞因子疗法，以治疗癌症和自身免疫性疾病患者，这些患者的医疗需求尚未得到满足。该公司利用蛋白质工程能力来增加对蛋白质结构和相互作用的理解，并设计新技术和具有改进特性的XmAb候选药物。","yearOnYearQuotes":[{"month":1,"riseRate":0.230769,"avgChangeRate":-0.060713},{"month":2,"riseRate":0.615385,"avgChangeRate":0.046082},{"month":3,"riseRate":0.230769,"avgChangeRate":-0.051854},{"month":4,"riseRate":0.153846,"avgChangeRate":-0.035695},{"month":5,"riseRate":0.538462,"avgChangeRate":0.016528},{"month":6,"riseRate":0.615385,"avgChangeRate":0.108196},{"month":7,"riseRate":0.615385,"avgChangeRate":0.020771},{"month":8,"riseRate":0.461538,"avgChangeRate":0.012524},{"month":9,"riseRate":0.384615,"avgChangeRate":0.008834},{"month":10,"riseRate":0.538462,"avgChangeRate":0.006015},{"month":11,"riseRate":0.916667,"avgChangeRate":0.149173},{"month":12,"riseRate":0.5,"avgChangeRate":0.005588}],"exchange":"NASDAQ","name":"Xencor Inc","nameEN":"Xencor"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Xencor Inc(XNCR)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Xencor Inc(XNCR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Xencor Inc,XNCR,Xencor Inc股票,Xencor Inc股票老虎,Xencor Inc股票老虎国际,Xencor Inc行情,Xencor Inc股票行情,Xencor Inc股价,Xencor Inc股市,Xencor Inc股票价格,Xencor Inc股票交易,Xencor Inc股票购买,Xencor Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Xencor Inc(XNCR)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Xencor Inc(XNCR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}